|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q91249391
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000215.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q91249391
|
|
024
|
|
|
‡a
0000-0003-2701-8924
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q91249391
|
|
100
|
0 |
|
‡a
Ivair R Silva
‡c
researcher (ORCID 0000-0003-2701-8924)
‡9
en
|
|
400
|
0 |
|
‡a
Ivair R Silva
‡c
onderzoeker
‡9
nl
|
|
670
|
|
|
‡a
Author's Alpha spending for historical versus surveillance Poisson data with CMaxSPRT
|
|
670
|
|
|
‡a
Author's Exact sequential analysis for multiple weighted binomial end points
|
|
670
|
|
|
‡a
Author's Type I error probability spending for post-market drug and vaccine safety surveillance with binomial data.
|
|
670
|
|
|
‡a
Author's Type I Error Probability Spending for Post-Market Drug and Vaccine Safety Surveillance With Poisson Data
|
|
909
|
|
|
‡a
(orcid) 0000000327018924
‡9
1
|
|
919
|
|
|
‡a
type1errorprobabilityspendingforpostmarketdrugandvaccinesafetysurveillancewithpoissondata
‡A
Type I Error Probability Spending for Post-Market Drug and Vaccine Safety Surveillance With Poisson Data
‡9
1
|
|
919
|
|
|
‡a
type1errorprobabilityspendingforpostmarketdrugandvaccinesafetysurveillancewithbinomialdata
‡A
Type I error probability spending for post-market drug and vaccine safety surveillance with binomial data.
‡9
1
|
|
919
|
|
|
‡a
exactsequentialanalysisformultipleweightedbinomialendpoints
‡A
Exact sequential analysis for multiple weighted binomial end points
‡9
1
|
|
919
|
|
|
‡a
alphaspendingforhistoricalversussurveillancepoissondatawithcmaxsprt
‡A
Alpha spending for historical versus surveillance Poisson data with CMaxSPRT
‡9
1
|
|
996
|
|
|
‡2
LC|no2024123877
|
|
996
|
|
|
‡2
ISNI|0000000066303005
|
|
996
|
|
|
‡2
BLBNB|000353198
|
|
996
|
|
|
‡2
PTBNP|94471
|
|
996
|
|
|
‡2
PTBNP|173967
|
|
996
|
|
|
‡2
DNB|1241062560
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
